Table 5.
Univariate analysis for grades 3-4 late subcutaneous toxicity in the whole series of patients (n = 26) and in patients who received higher doses of RT (n = 19)
| HR | (95% CI) | P | |
|---|---|---|---|
| Whole series | |||
| Age | 1.012 | (0.975-1.012) | 0.535 |
| Received dose | 1.079 | (0.980-1.189) | 0.123 |
| Maximum dose | 1.054 | (0.991-1.121) | 0.096 |
| Bra size | 1.056 | (1.003-1.111) | 0.037 |
| Systemic treatment | 1.084 | (0.351-3.347) | 0.888 |
| Low DSB-High RIA 1Gy | 0.564 | (0.233-1.370) | 0.206 |
| Low DSB-High RIA 2Gy | 0.510 | (0.204-1.277) | 0.150 |
| Low DSB-High RIA 8Gy | 0.642 | (0.270-1.523) | 0.314 |
| Higher dose (≥81.6Gy) | |||
| Low DSB-High RIA 1Gy | 0.252 | (0.077-0.826) | 0.023 |
| Low DSB-High RIA 2Gy | 0.197 | (0.053-0.735) | 0.016 |
| Low DSB-High RIA 8Gy | 0.240 | (0.074-0.778) | 0.017 |
Abbreviations: HR = hazard ratio; CI = confidence interval